Malvern, PA, United States of America

Stewart McCallum

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Baudax Bio, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stewart McCallum. Retrieved from https://idiyas.com/inventor/stewart-mccallum-7bujglq4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Stewart McCallum: Innovator in Pain Management for Elderly Patients

Introduction

Stewart McCallum is a notable inventor based in Malvern, PA, who has made significant contributions to the field of pain management. His innovative approach focuses on treating pain in elderly patients, particularly those with mild renal impairment.

Latest Patents

McCallum holds a patent for a method of treating pain in elderly patients with mild renal impairment. This patent details the administration of meloxicam intravenously, which provides a fast onset of pain relief suitable for managing both acute and moderate to severe pain in patients aged 65 and older.

Career Highlights

Stewart McCallum is associated with Baudax Bio, Inc., where he applies his expertise in pain management. His work is crucial in developing effective treatments that cater to the unique needs of elderly patients, ensuring they receive appropriate care.

Collaborations

Some of his coworkers include Randall J Mack and Alexis Gomez, who contribute to the innovative environment at Baudax Bio, Inc. Their collaboration fosters advancements in medical treatments and enhances the quality of care for patients.

Conclusion

Stewart McCallum's contributions to pain management for elderly patients highlight the importance of innovation in healthcare. His patent for administering meloxicam intravenously represents a significant step forward in providing effective pain relief for a vulnerable population.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…